These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5154400)

  • 1. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G
    Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F
    Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of clofibrate (Atromid-S) on serum lipids in man.
    Hunninghake DB; Tucker DR; Azarnoff DL
    Circulation; 1969 May; 39(5):675-83. PubMed ID: 5787318
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hyperlipidemic states.
    Strisower EH; Adamson G; Strisower B
    Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hyperlipidemias.
    Strisower EH; Adamson G; Strisower B
    Am J Med; 1968 Oct; 45(4):488-501. PubMed ID: 5678093
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipoproteinemias in the prematurely aged. Theories of pathogenesis, diagnosis, classification, and treatment.
    Herrmann GR
    Geriatrics; 1970 Apr; 25(4):103-14. PubMed ID: 5443794
    [No Abstract]   [Full Text] [Related]  

  • 17. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 18. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
    Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
    Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.